Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3-Year Randomized Placebo-Controlled Clinical Trial With a 2-Year Open Extension
Caroline Brumsen(Leiden University Medical Center), Aeilko H. Zwinderman(Amsterdam Neuroscience), Socrates E. Papapoulos(Leiden University Medical Center), Paul Lips(Amsterdam University Medical Centers), J. C. Netelenbos(Amsterdam UMC Location Vrije Universiteit Amsterdam), Petronella Geelhoed-Duijvestijn(Rijnstate Hospital), Neveen A. T. Hamdy(Leiden University Medical Center), Jan C. Roos(Vrije Universiteit Amsterdam), Jan Otto Landman(Leiden University Medical Center), R. M. Valentijn(Rode Kruis Ziekenhuis), Ernest K. J. Pauwels(Leiden University Medical Center), Eugène McCloskey(Arthritis UK)
Cited by 83
Related Papers
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
The Athlete’s Heart
|Circulation|2000|1.1k